Canada’s newly announced Nuclear Energy Strategy is energy and economic policy, but from an intellectual property (IP) perspective, it is also a clear signal that the federal government is preparing to shape who owns, controls, and exports the next generation of nuclear technology. The emphasis on “energy sovereignty,” “Canadian‑controlled” systems, and export leadership tells a familiar story: public money is being used not just to accelerate technology, but to steer its downstream IP outcomes.
The planned strategy rests heavily on Canada’s existing nuclear strengths—CANDU technology (CAnada Deuterium Uranium), uranium production, and a mature safety regime—but its future-facing value sits squarely in new builds, small modular reactors, and emerging fission and fusion innovation. These are precisely the areas where patent portfolios, manufacturing know‑how, and IP licensing structures will determine who captures long‑term value. For companies and research organizations involved, this is not a “wait for the regulations” moment; this is when IP positions are quietly set.
Part of the nuclear strategy includes a ten‑year, $2.2‑billion commitment to Chalk River Laboratories which is noteworthy. Investments of this scale in national labs reliably generate patentable inventions, incremental technology improvements, and platform technologies. The Government of Canada's press release on the strategy makes clear that this work will span reactor fuel development, advanced materials, small modular reactors, and life‑extension technologies. Each of those categories historically raises hard questions about background IP, Crown-developed technology, and rights in improvements. Without deliberate planning, it could be very easy for valuable IP to become encumbered by unclear ownership or broad government use rights that later complicate commercialization.
Another aspect of the strategy, the Department of National Defence’s $40‑million microreactor feasibility program further sharpens the picture. The repeated use of the phrase “Canadian‑controlled” should be read carefully. In IP terms, this usually translates into expectations around ownership, control, security of supply, and limits on foreign influence over core technology. Companies participating in defence‑adjacent nuclear projects should assume that IP provisions will eventually matter as much as technical success, particularly if export opportunities are part of the long‑term business case.
It is tempting to think that regulatory complexity—CNSC (Canadian Nuclear Safety Commission) approvals, environmental reviews, and northern engagement—buys time on the IP front. However, patent timelines are indifferent to licensing schedules, and early‑stage disclosures, pilot facilities, and public funding announcements can all have downstream consequences for novelty and foreign filing rights. The fact that deployment may be years away does not reduce the urgency of getting IP strategy right now.
Finally, the strategy’s emphasis on manufacturing capability and innovation has implications beyond terrestrial power. As space agencies increasingly explore nuclear fission for lunar and deep‑space applications, Canada’s effort to industrialize advanced reactor technologies today could position Canadian IP for future off‑world licensing and collaboration. That opportunity only materializes, however, if companies and institutions retain clean, well‑structured patent and know‑how rights.
The call to action is simple: for companies receiving nuclear‑related public funding, now is the time to map IP ownership, clarify improvement rights, file earlier than feels necessary, and plan for export and defence sensitivities from day one. Nuclear strategy may be set in Ottawa, but IP value is won—or lost—in the fine print long before a reactor is switched on.